D. Gray Heppner

10.3k total citations · 2 hit papers
76 papers, 5.7k citations indexed

About

D. Gray Heppner is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, D. Gray Heppner has authored 76 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 22 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in D. Gray Heppner's work include Malaria Research and Control (58 papers), Mosquito-borne diseases and control (34 papers) and vaccines and immunoinformatics approaches (17 papers). D. Gray Heppner is often cited by papers focused on Malaria Research and Control (58 papers), Mosquito-borne diseases and control (34 papers) and vaccines and immunoinformatics approaches (17 papers). D. Gray Heppner collaborates with scholars based in United States, Thailand and Belgium. D. Gray Heppner's co-authors include Kent E. Kester, Joe Cohen, Urszula Krzych, W. Ripley Ballou, José A. Stoute, Nathalie Garçon, Daniel M. Gordon, Christian F. Ockenhouse, M. Slaoui and Megan Dowler and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

D. Gray Heppner

76 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria

1997 652 citations José A. Stoute, D. Gray Heppner et al. profile →
Protection of Humans against Malaria by Immunization with Radiation‐AttenuatedPlasmodium falciparumSporozoites

2002 526 citations Megan Dowler, Daniel M. Gordon et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Gray Heppner United States	40	3.8k	1.8k	1.7k	834	819	76	5.7k
Michael R. Hollingdale United States	36	3.7k 1.0×	1.7k 0.9×	2.1k 1.2×	345 0.4×	689 0.8×	106	5.4k
Sanjai Kumar United States	39	2.6k 0.7×	1.7k 0.9×	1.4k 0.8×	729 0.9×	600 0.7×	125	4.6k
Thomas L. Richie United States	37	3.4k 0.9×	1.3k 0.7×	1.2k 0.7×	584 0.7×	502 0.6×	124	4.8k
Alan W. Thomas Netherlands	52	5.9k 1.5×	2.6k 1.5×	2.0k 1.2×	980 1.2×	1.2k 1.4×	124	8.4k
Kent E. Kester United States	34	2.8k 0.7×	1.6k 0.9×	1.8k 1.0×	769 0.9×	813 1.0×	54	4.7k
W. Ripley Ballou United States	31	2.9k 0.8×	1.3k 0.7×	1.5k 0.9×	476 0.6×	564 0.7×	59	4.1k
Louis Schofield Australia	51	5.7k 1.5×	3.7k 2.1×	1.6k 0.9×	443 0.5×	1.4k 1.7×	104	8.3k
Adrian J. F. Luty Netherlands	47	4.6k 1.2×	2.4k 1.3×	860 0.5×	649 0.8×	752 0.9×	163	6.7k
Kalifa Bojang Gambia	37	3.3k 0.9×	914 0.5×	815 0.5×	605 0.7×	529 0.6×	83	4.6k
Chetan E. Chitnis India	48	6.1k 1.6×	3.4k 1.9×	1.5k 0.9×	370 0.4×	875 1.1×	142	8.0k

Countries citing papers authored by D. Gray Heppner

Since Specialization

Citations

This map shows the geographic impact of D. Gray Heppner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gray Heppner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gray Heppner more than expected).

Fields of papers citing papers by D. Gray Heppner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gray Heppner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gray Heppner. The network helps show where D. Gray Heppner may publish in the future.

Co-authorship network of co-authors of D. Gray Heppner

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gray Heppner. A scholar is included among the top collaborators of D. Gray Heppner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gray Heppner. D. Gray Heppner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kester, Kent E., D. Gray Heppner, Philippe Moris, et al.. (2014). Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults. Vaccine. 32(49). 6683–6691. 32 indexed citations

Lumsden, Joanne M., Robert Schwenk, Lisa Rein, et al.. (2011). Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells. PLoS ONE. 6(7). e20775–e20775. 68 indexed citations

Polhemus, Mark E., Shon Remich, Bernhards Ogutu, et al.. (2009). Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area. PLoS ONE. 4(7). e6465–e6465. 94 indexed citations

Dutta, Sheetij, JoAnn S. Sullivan, Katharine K. Grady, et al.. (2009). High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model. PLoS ONE. 4(12). e8138–e8138. 68 indexed citations

Waitumbi, John, Samuel B. Anyona, Mark E. Polhemus, et al.. (2009). Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial. PLoS ONE. 4(11). e7849–e7849. 39 indexed citations

Shott, Joseph P., Shannon McGrath, Maria Grazia Pau, et al.. (2008). Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-γ and antibody responses in mice. Vaccine. 26(23). 2818–2823. 38 indexed citations

Heppner, D. Gray, Robert Schwenk, David E. Arnot, Robert W. Sauerwein, & Adrian J. F. Luty. (2007). The dog that did not bark: malaria vaccines without antibodies. Trends in Parasitology. 23(7). 293–296. 6 indexed citations

Polhemus, Mark E., et al.. (2007). Hb Kenya among Luo Adults and Young Children in Malaria Holoendemic Western Kenya: Screened by High Performance Liquid Chromatography and Confirmed By Polymerase Chain Reaction. Hemoglobin. 31(4). 401–408. 7 indexed citations

Stewart, V. Ann, Douglas S. Walsh, Shannon McGrath, et al.. (2006). Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques. Vaccine. 24(42-43). 6493–6502. 28 indexed citations

10.

Macete, Eusébio, John J. Aponte, Caterina Guinovart, et al.. (2006). Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique. Tropical Medicine & International Health. 12(1). 37–46. 30 indexed citations

11.

Sun, Peifang, Robert Schwenk, Katherine White, et al.. (2003). Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ. The Journal of Immunology. 171(12). 6961–6967. 183 indexed citations

12.

Hirunpetcharat, Chakrit, Jiraprapa Wipasa, Supachai Sakkhachornphop, et al.. (2003). CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP119) formulated in oil-based Montanides. Vaccine. 21(21-22). 2923–2932. 42 indexed citations

13.

Ballou, W. Ripley, Kent E. Kester, & D. Gray Heppner. (2002). Pre-Erythrocytic Malaria Vaccines to Prevent <i>Plasmodium falciparum</i> Malaria. PubMed. 80. 253–261. 4 indexed citations

14.

Pichyangkul, Sathit, Kosol Yongvanitchit, Utaiwan Kum-Arb, et al.. (2001). Whole blood cultures to assess the immunostimulatory activities of CpG oligodeoxynucleotides. Journal of Immunological Methods. 247(1-2). 83–94. 32 indexed citations

15.

Kester, Kent E., Denise McKinney, Nadia Tornieporth, et al.. (2001). Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalaria. The Journal of Infectious Diseases. 183(4). 640–647. 199 indexed citations

16.

Wongsrichanalai, Chansuda, T Wimonwattrawatee, P Sookto, et al.. (1999). In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand.. PubMed. 77(5). 392–8. 37 indexed citations

17.

Sabchareon, Arunee, P. Attanath, Pornthep Chanthavanich, et al.. (1998). Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.. American Journal of Tropical Medicine and Hygiene. 58(1). 11–16. 33 indexed citations

18.

Wongsrichanalai, Chansuda, et al.. (1997). In vitro susceptibility of Plasmodium falciparum isolates in Vietnam to artemisinin derivatives and other antimalarials. Acta Tropica. 63(2-3). 151–158. 22 indexed citations

19.

Nosten, François, Christine Luxemburger, Dennis E. Kyle, et al.. (1996). Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. The Lancet. 348(9029). 701–707. 130 indexed citations

20.

Suharyono, Suharyono, C. H. Simanjuntak, Narain H. Punjabi, et al.. (1992). Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. The Lancet. 340(8821). 689–694. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact